SC 13G Filing

Company

Bolt Biotherapeutics, Inc.

Filed

April 20, 2023

Accession Number

0001214659-23-005704

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →